| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888322 Use of VEGF and homologues to treat neuron disorders |
| 02/15/2011 | US7888321 Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses |
| 02/15/2011 | US7888318 Method of preparing an organ by perfusion |
| 02/15/2011 | US7888317 Glucagon-like peptide-2 and its therapeutic use |
| 02/15/2011 | US7888315 Use of aspartic proteases in cosmetics and therapeutics |
| 02/15/2011 | US7888313 Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein |
| 02/15/2011 | US7888311 for decontaminating soils and water; for detecting and treating people contaminated by uranium |
| 02/15/2011 | US7888291 Substrates and assays for β-secretase |
| 02/15/2011 | US7888133 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 02/15/2011 | US7888122 transgenic plant comprising in its genome a transgene encoding a member FLOWERING LOCUS C (FLC) gene family; having early timing of its flowering; seeds; genetic engineering |
| 02/15/2011 | US7888121 Methods and compositions for targeted cleavage and recombination |
| 02/15/2011 | US7888117 for increasing the expression of an OCT-2 responsive gene |
| 02/15/2011 | US7888115 Major histocompatibility complex amino acid sequences for use as tool in developing antibodies and vaccine for use in prevention and treatment of cell proliferative disorders; immunotherapy |
| 02/15/2011 | US7888112 Isolated polynucleotides comprising a nucleic acid which operably encodes 50 contiguous amino acids, nucleic acids are fragments of a codon-optimized coding region; a carrier |
| 02/15/2011 | US7888101 involving overexpression of alpha 1,2 mannosidase (MAN1C1) activity to improve protein production; improved glycoprotein production |
| 02/15/2011 | US7888086 mutant hydrolase forms stable bond with dehalogenase substrate; beta-lactamases; fusion proteins; cell labelling; tissue target therapy |
| 02/15/2011 | US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888070 in which the RSP sorting signal has been mutated such that the GH can be constitutively secreted by the nonregulated secretory pathway (NRSP) in a mammalian cell |
| 02/15/2011 | US7888066 Diagnosing nervous system disorders; obtain tissue sample, measure expression of semaphorin 3 and downstream effectors , amplified concentrations of semaphorins indicate nervous system disorders; drug screening |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7888046 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof |
| 02/15/2011 | US7888045 Methods for identifying modulators of SF taste receptor signaling |
| 02/15/2011 | US7888042 Methods for identifying insulin mimetics |
| 02/15/2011 | US7888040 highly specific; methamphetamine, ecstacy, (+/-)-N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) and (+/-)-3,4-methylenedioxyethylamphetamine (MDEA); for use in the laboratory, point-of-care and on-site testing; without significant interference from other phenyethylamine derivatives |
| 02/15/2011 | US7888038 modulating apoptosis-induced cell death comprising modulating the level of Bak Binding Protein (BBP) in a eukaryotic cell; drug screening |
| 02/15/2011 | US7887819 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 02/15/2011 | US7887818 Neospora caninum vaccine |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | US7887814 binding proteins, fused with transferrins; for treatment of Alzheimer's, Down Syndrome, infant encephalitis, AIDS, and autoimmune diseases |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887808 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887805 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887800 activating endothelial growth factors VEGF-C or vascular endothelial growth factor D (VEGF-D) with plasmin; Angiogenesis |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887798 Methods of treating cancer by administering antibodies to CD200 |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | CA2519993C Ph-dependent polypeptide aggregation and its use |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2439067C Lentiviral packaging constructs |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2429473C Membrane scaffold proteins |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2356701C Gene therapy for diabetic ischemic disease |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/15/2011 | CA2311389C Antimicrobial peptides |
| 02/15/2011 | CA2301826C Chimeric binding peptide library screening method |
| 02/15/2011 | CA2295332C Aib1, a novel steroid receptor co-activator |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2223616C Hypersensitive response induced resistance in plants |
| 02/15/2011 | CA2200691C Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/15/2011 | CA2074370C Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 02/10/2011 | WO2011017492A2 Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
| 02/10/2011 | WO2011017442A2 Anti-rsv immunogens and methods of immunization |
| 02/10/2011 | WO2011017162A2 Methods for enhancing antigen-specific immune responses |
| 02/10/2011 | WO2011017160A1 Mutant human interferon proteins and genes |
| 02/10/2011 | WO2011017132A2 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 02/10/2011 | WO2011017107A2 Microbubble assisted viral delivery |
| 02/10/2011 | WO2011016632A2 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor |
| 02/10/2011 | WO2011015633A1 Method of producing a sweet protein |
| 02/10/2011 | WO2011015628A1 Novel antipathogenic peptides |
| 02/10/2011 | WO2011015590A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | WO2011015121A1 Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 02/10/2011 | WO2011014947A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | WO2010115156A3 Endophytic fungus and uses therefor |
| 02/10/2011 | WO2010081007A3 Carbonic anhydrase polypeptides and uses thereof |
| 02/10/2011 | WO2009158618A8 Avian reoviridae |
| 02/10/2011 | WO2009133126A3 Compositions and methods of using rna interference for the control of nematodes |
| 02/10/2011 | US20110035846 Transcriptional repressor peptides and genes for the same |
| 02/10/2011 | US20110035843 Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
| 02/10/2011 | US20110035842 Soybean promoters sc194 and flower-preferred expression thereof in transgenic plants |
| 02/10/2011 | US20110035841 Lipid Metabolism Proteins, Combinations of Lipid Metabolism Proteins and Uses Thereof |
| 02/10/2011 | US20110035835 Methods for Enhancing Stress Tolerance in Plants and Compositions Thereof |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034752 Therapeutic regimen for treating cancer |
| 02/10/2011 | US20110034737 Water-Soluble Polymer Alkanals |
| 02/10/2011 | US20110034676 Anti-sialic acid antibody molecules |
| 02/10/2011 | US20110034671 Systems for Expression of Heterologous Proteins in M. Capsulatus |
| 02/10/2011 | US20110034543 DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034400 Compositions and methods for analyzing bacterial adherence and anti-adherence to mucus, epithelial cells and other cells |
| 02/10/2011 | US20110034390 Peptides, compositions, and uses thereof |
| 02/10/2011 | US20110034389 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 02/10/2011 | US20110034385 Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder |
| 02/10/2011 | US20110034383 Cxcl12 gamma a chemokine and uses thereof |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110034377 Exendin and Exendin Agonists for Eating Disorders |
| 02/10/2011 | US20110034374 Oxyntomodulin for Preventing or Treating Excess Weight |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110034368 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 02/10/2011 | US20110033929 Uses of antibodies to mammalian dc langerhans cell antigen |
| 02/10/2011 | US20110033926 Production Of Viral Vectors |
| 02/10/2011 | US20110033923 Marker for stem cells and its use |
| 02/10/2011 | US20110033911 Episomal fusion gene |